These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 23906420)
1. Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Hanai Y; Takahashi Y; Niwa T; Mayumi T; Hamada Y; Kimura T; Matsumoto K; Fujii S; Takesue Y J Antimicrob Chemother; 2022 Mar; 77(4):869-879. PubMed ID: 35022752 [TBL] [Abstract][Full Text] [Related]
2. Osteoarticular infections: a specific program for older patients? Uçkay I; Holy D; Betz M; Sauer R; Huber T; Burkhard J Aging Clin Exp Res; 2021 Mar; 33(3):703-710. PubMed ID: 31494913 [TBL] [Abstract][Full Text] [Related]
3. Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose. Pea F; Brollo L; Viale P; Pavan F; Furlanut M J Antimicrob Chemother; 2003 Apr; 51(4):971-5. PubMed ID: 12654757 [TBL] [Abstract][Full Text] [Related]
4. Teicoplanin population pharmacokinetic analysis in hospitalized patients. Soy D; López E; Ribas J Ther Drug Monit; 2006 Dec; 28(6):737-43. PubMed ID: 17164688 [TBL] [Abstract][Full Text] [Related]
5. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809 [TBL] [Abstract][Full Text] [Related]
6. Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation. Yamada T; Nonaka T; Yano T; Kubota T; Egashira N; Kawashiri T; Oishi R Int J Antimicrob Agents; 2012 Oct; 40(4):344-8. PubMed ID: 22818770 [TBL] [Abstract][Full Text] [Related]
7. [Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy in geriatric patients]. Uhart M; Leroy B; Michaud A; Maire P; Bourguignon L Med Mal Infect; 2013 Jul; 43(7):295-8. PubMed ID: 23906420 [TBL] [Abstract][Full Text] [Related]
8. [Level of evidence for therapeutic drug monitoring of teicoplatin]. Boulamery A; Venisse N; Le Guellec C; Therapie; 2011; 66(1):45-50. PubMed ID: 21466777 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin]. Paganini H; Marin M Medicina (B Aires); 2002; 62 Suppl 2():52-5. PubMed ID: 12481490 [TBL] [Abstract][Full Text] [Related]